Stockscreener 앱 받기
0.365
2.46%
-0.0092
시간 외 거래:
.35
-0.015
-4.11%
전일 마감가:
$0.3742
열려 있는:
$0.3898
하루 거래량:
73,919
Relative Volume:
0.07
시가총액:
$6.27M
수익:
$414.60K
순이익/손실:
$-19.21M
주가수익비율:
-0.2252
EPS:
-1.6207
순현금흐름:
$-4.89M
1주 성능:
-22.34%
1개월 성능:
+1.36%
6개월 성능:
-53.21%
1년 성능:
-77.88%
1일 변동 폭
$0.365
$0.3898
1주일 범위
$0.34
$0.4502
52주 변동 폭
$0.162
$2.75
Mangoceuticals Inc Stock (MGRX) Company Profile
명칭
Mangoceuticals Inc
전화
(833) 626-4679
주소
15110 DALLAS PKWY, SUITE 600, DALLAS
Compare MGRX vs VEEV, BTSG, TEM, HQY, HNGE
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
0.365 | 6.27M | 414.60K | -19.21M | -4.89M | -1.6207 |
VEEV
Veeva Systems Inc
|
190.12 | 30.88B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
71.43 | 14.02B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
58.23 | 10.46B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
94.40 | 7.89B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
88.80 | 6.87B | 646.34M | -512.40M | 202.76M | -6.6871 |
Mangoceuticals Inc 주식(MGRX)의 최신 뉴스
Price to sales forward of Mangoceuticals, Inc. – BOATS:MGRX - TradingView
Price to earnings forward of Mangoceuticals, Inc. – NASDAQ:MGRX - TradingView
ETFs Investing in Mangoceuticals, Inc. Stocks - TradingView
Mangoceuticals, Inc. Subscription Agreement: Accredited Investor Requirements & SEC Compliance Explained - Minichart
Mangoceuticals Raises Capital via Private Equity Placement - TipRanks
Mangoceuticals (MGRX) completes $272,000 private placement of common shares - Stock Titan
Mangoceuticals, Inc. announced that it has received $0.272 million in funding - marketscreener.com
Mangoceuticals Inc (MGRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Mangoceuticals Inc (MGRX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Mangoceuticals Inc (MGRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Trending Stocks Today | Mangoceuticals Soars 41.16% Post-Market - Moomoo
MGRX Q3 2025 Earnings: Widening Losses and No Revenue as Mangoceuticals Navigates Pre‑Commercial Phase - dars.gov.et
Mangoceuticals Inc (MGRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Mangoceuticals Inc (MGRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Mangoceuticals Inc (MGRX) Institutional Confidence - TradingKey
Mangoceuticals Inc (MGRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mangoceuticals Inc (MGRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mangoceuticals Inc (MGRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MGRX Q3 2025 Earnings: Loss Per Share Pressures Stock as Revenue Remains UndisclosedPeak Earnings Alert - dars.gov.et
MGRX Q3 2025 Earnings: EPS Loss of -$0.69 Highlights Ongoing Operational ChallengesPerformance Review - newsline.com
MGRX Price Today: Mangoceuticals, Inc. Stock Price, Quote & Chart | MEXC - MEXC
MGRX Q3 2025 Earnings: Loss Reported, No Revenue Disclosed as Stock DeclinesLong-Term Guidance - dars.gov.et
MGRX Technical Analysis & Stock Price Forecast - Intellectia AI
Number of shareholders of Mangoceuticals, Inc. – NASDAQ:MGRX - TradingView
MGRX Q3 2025 Earnings: EPS of -$0.69 Reflects Ongoing Investment; Shares Dip 2.56%Subscription Growth Report - The Legal Advocate
MGRX Stock Price, Quote & Chart | MANGOCEUTICALS INC (NASDAQ:MGRX) - ChartMill
MGRX Q3 2025 Earnings: Narrowing Losses as Strategic Pivot Gains MomentumEarnings Miss Streak - newsline.com
MGRXMangoceuticals Inc Stock Price and Quote - Finviz
MGRX Q3 2025 Earnings: EPS Surprises with -$0.69 Loss as Revenue Remains UndisclosedROA Comparison - The Legal Advocate
Mangoceuticals Inc. (MGRX) Holds Near $0.44 After Marginal Uptick — Support and Resistance TightenVolume Profile - Newser
MANGOCEUTICALS, INC. 1Q 2026: Revenue $67.9K, EPS $(0.22) — 10-Q Summary - TradingView
Mangoceuticals (NASDAQ: MGRX) Q1 2026 shows small sales, heavy loss and thin cash - Stock Titan
MGRX: Net loss narrowed but liquidity and Nasdaq compliance risks persist, requiring urgent funding - TradingView
Mangoceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Mangoceuticals Delays Quarterly Filing After Audit Review - TipRanks
[NT 10-Q] MANGOCEUTICALS, INC. SEC Filing - Stock Titan
MGRX (Mangoceuticals) Q3 loss widens, but stock rallies 7% on positive outlook.Rating Upgrade - Newser
Mangoceuticals stock doubles after Texas lawsuit - MSN
Is Mangoceuticals (MGRX) stock near support |Real-time Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Mangoceuticals (MGRX) Stock: Market Structure (Buying Pressure) 2026-04-20Collaborative Trading Signals - Newser
Mangoceuticals (MGRX) Stock: Should You Take Exposure (Smart Money Exits) 2026-04-18Top Analyst Buy Signals - Xã Thanh Hà
Mangoceuticals Inc. (MGRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Aug Final Week: Can Mangoceuticals Inc expand its profit marginsBull Run & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Support Test: Will Mangoceuticals Inc outperform tech stocksMarket Trend Report & Technical Pattern Based Signals - baoquankhu1.vn
Ideas Watch: Can Mangoceuticals Inc expand into new markets2026 Selloffs & Reliable Volume Spike Alerts - baoquankhu1.vn
Is Mangoceuticals (MGRX) Stock Breaking Out | Price at $0.34, Up 0.30%Ichimoku Kumo Twist - newsline.com
Aug Chart Watch: Does Mangoceuticals Inc have a sustainable dividendQuarterly Trade Review & AI Enhanced Trading Alerts - baoquankhu1.vn
Head to Head Analysis: Lyell Immunopharma (NASDAQ:LYEL) & Mangoceuticals (NASDAQ:MGRX) - Defense World
Institution Moves: Will Mangoceuticals Inc benefit from seasonality2026 Big Picture & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Mangoceuticals Inc stock falls amid market weakness - Intellectia AI
Securities.io - Securities.io
Mangoceuticals Inc (MGRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.61%
자본화:
|
볼륨(24시간):